Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 15 Dec 2006

Baz Mariana, Abed Yacine, McDonald Jane, Boivin Guy

Abstract excerpt

BACKGROUND: Development of influenza drug resistance is an important problem in immunocompromised children that could result in treatment failure and viral transmission to others. METHODS: A total of 17 influenza A/H3N2 isolates were recovered over a period of 1 year from an immunocompromised child who was initially treated with oseltamivir and then with amantadine and zanamivir for viral pneumonitis. Drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclopentanes
Share to Drug Resistance, Multiple

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Guanidines

Share to Immunocompromised Host

Share to Influenza A Virus, H3N2 Subtype

Share to Oseltamivir

Share to Zanamivir

Source

Identifiers

PMID: 17109288
DOI: 10.1086/508777

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child.PMID 17109288Read ↗

Prolonged shedding of amantadine- and oseltamivir-resistant influenza A(H3N2) virus with dual mutations in an immunocompromised infant.Semantic proximity Read ↗

Recovery of drug-resistant influenza virus from immunocompromised patients: a case series.Semantic proximity Read ↗

Molecular pathway of influenza pan-neuraminidase inhibitors resistance in an immunocompromised patientSemantic proximity Read ↗

Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea.Semantic proximity Read ↗

Prolonged excretion of amantadine-resistant influenza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient.Semantic proximity Read ↗

A Novel Neuraminidase Deletion Mutation Conferring Resistance to Oseltamivir in Clinical Influenza A/H3N2 VirusSemantic proximity Read ↗

Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of KoreaSemantic proximity Read ↗

Recovery of a Multidrug‐Resistant Strain of Pandemic Influenza A 2009 (H1N1) Virus Carrying a Dual H275Y/I223R Mutation from a Child after Prolonged Treatment with OseltamivirSemantic proximity Read ↗

Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014.Semantic proximity Read ↗

Multidrug-resistant pandemic (H1N1) 2009 infection in immunocompetent child.Semantic proximity Read ↗

Multiple influenza A (H3N2) mutations conferring resistance to neuraminidase inhibitors in a bone marrow transplant recipient.Semantic proximity Read ↗

Emergence of G186D mutation in the presence of R292K mutation in an immunocompromised child infected with influenza A/H3N2 virus, treated with oseltamivir.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.